Comparing Armodafinil vs Caffeine
Armodafinil | Caffeine |
|
---|
Armodafinil | Caffeine |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for ADHD, Chronic Fatigue Syndrome, Bipolar Disorder, Obstructive Sleep Apnea/Hypopnea Syndrome, Narcolepsy, Shift Work Sleep Disorder, Depression, Fibromyalgia, Idiopathic Hypersomnia... View more |
Prescription and OTC
Prescribed for Drowsiness, Asthma, Apnea of Prematurity. caffeine may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Armodafinil | More about Caffeine | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Armodafinil has an average rating of 7.3 out of 10 from a total of 429 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 17% reported a negative effect. |
Caffeine has an average rating of 7.1 out of 10 from a total of 39 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
See also: armodafinil side effects in more detail. |
See also: caffeine side effects in more detail. |
||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all armodafinil prices |
View all caffeine prices |
||||||||||||||||
Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Nuvigil | 357 HR Magnum, Alert, Cafcit, Caffedrine, ConRx Alert, Diurex Maximum Relief Water Caps, Diurex Ultra, Enerjets, Fastlene, Jet Alert Double Strength, Jet Alert Maximum Strength, Jet Alert Regular Strength, Keep Going, Molie, NoDoz, Overtime, Pep-Back ReCharge, Pep-Back Ultra, Stay Awake, Valentine, Vivarin View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
15 hours |
4 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Caffeine Citrate Injection
Category N
Not classified
Excluding Caffeine Citrate Injection See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 496 drugs are known to interact with armodafinil:
|
A total of 107 drugs are known to interact with caffeine:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
June 15, 2007 |
September 21, 1999 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.